$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224046738 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$1.196M	$10.00K
YoY Change		11860.0%	-28.57%
Cost Of Revenue			$70.00K
YoY Change			400.0%
Gross Profit			-$60.00K
YoY Change
Gross Profit Margin			-600.0%
Selling, General & Admin		$1.733M	$4.717M
YoY Change		-63.26%	-42.96%
% of Gross Profit
Research & Development		$43.00K	$283.0K
YoY Change		-84.81%	-49.28%
% of Gross Profit
Depreciation & Amortization		$17.00K	$75.00K
YoY Change		-77.33%	7.14%
% of Gross Profit
Operating Expenses		$2.201M	$3.447M
YoY Change		-36.15%	-60.95%
Operating Profit		-$1.005M	-$3.507M
YoY Change		-71.34%	-60.21%
Interest Expense			$148.0K
YoY Change			-65.09%
% of Operating Profit
Other Income/Expense, Net		-$948.0K	-$41.00K
YoY Change		2212.2%	-94.74%
Pretax Income		-$1.953M	-$3.660M
YoY Change		-46.64%	-91.08%
Income Tax
% Of Pretax Income
Net Earnings		-$1.946M	-$3.660M
YoY Change		-46.83%	-91.08%
Net Earnings / Revenue		-162.71%	-36600.0%
Basic Earnings Per Share
Diluted Earnings Per Share			-$0.75
COMMON SHARES
Basic Shares Outstanding	17.48M shares	13.63M shares	51.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$42.00K
YoY Change		-99.6%
Cash & Equivalents	$34.00K	$42.00K
Short-Term Investments
Other Short-Term Assets	$162.0K	$106.0K
YoY Change	52.83%	430.0%
Inventory		$1.131M
Prepaid Expenses	$502.0K
Receivables	$2.001M
Other Receivables
Total Short-Term Assets	$2.909M	$2.585M
YoY Change	12.53%	-85.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$387.0K
YoY Change
Goodwill	$33.16M
YoY Change
Intangibles	$2.105M
YoY Change
Long-Term Investments
YoY Change
Other Assets		$118.0K
YoY Change		-99.5%
Total Long-Term Assets	$39.76M	$546.0K
YoY Change	7182.42%	-98.98%
TOTAL ASSETS
Total Short-Term Assets	$2.909M	$2.585M
Total Long-Term Assets	$39.76M	$546.0K
Total Assets	$42.67M	$3.131M
YoY Change	1262.86%	-95.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.204M	$4.816M
YoY Change	70.35%	77.97%
Accrued Expenses	$12.56M	$1.528M
YoY Change	721.79%	205.6%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$4.006M
YoY Change
Total Short-Term Liabilities	$34.35M	$13.52M
YoY Change	154.12%	-59.06%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$100.0K	$718.0K
YoY Change	-86.07%	-96.59%
Total Long-Term Liabilities	$100.0K	$718.0K
YoY Change	-86.07%	-97.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.35M	$13.52M
Total Long-Term Liabilities	$100.0K	$718.0K
Total Liabilities	$60.23M	$14.23M
YoY Change	323.11%	-74.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.7M	-$172.3M
YoY Change	6.64%	33.65%
Common Stock	$1.000K	$6.000K
YoY Change	-83.33%	100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$17.51M	-$11.10M
YoY Change
Total Liabilities & Shareholders Equity	$42.67M	$3.131M
YoY Change	1262.86%	-95.62%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.946M	-$3.660M
YoY Change	-46.83%	-91.08%
Depreciation, Depletion And Amortization	$17.00K	$75.00K
YoY Change	-77.33%	7.14%
Cash From Operating Activities		-$865.0K
YoY Change		-79.74%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		692.0K
YoY Change		-120.97%
NET CHANGE
Cash From Operating Activities		-865.0K
Cash From Investing Activities		0.000
Cash From Financing Activities		692.0K
Net Change In Cash		-173.0K
YoY Change		-97.85%
FREE CASH FLOW
Cash From Operating Activities		-$865.0K
Capital Expenditures		$0.00
Free Cash Flow		-$865.0K
YoY Change		-81.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	34347000	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	100000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	60225000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	166218000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183727000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-17508000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17554000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42671000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1196000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1231000	usd
CY2023Q3	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues	70000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	312000	usd
CY2024Q3	FOXO	Management Contingent Share Plan Expense ManagementContingentSharePlanExpense	-116000	usd
CY2023Q3	FOXO	Management Contingent Share Plan Expense ManagementContingentSharePlanExpense	-1553000	usd
	FOXO	Management Contingent Share Plan Expense ManagementContingentSharePlanExpense	-75000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1733000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4717000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4195000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3447000	usd
	us-gaap	Operating Expenses OperatingExpenses	5004000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1005000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3507000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3773000	usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-36000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1800000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-49000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-948000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-153000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1848000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1953000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3660000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5621000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-1953000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-3660000	usd
	us-gaap	Profit Loss ProfitLoss	-5621000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1946000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5613000	usd
CY2024Q3	FOXO	Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	88000	usd
CY2023Q3	FOXO	Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	912000	usd
	FOXO	Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	1054000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2034000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4572000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6667000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001812360
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q4	FOXO	Supplies Current SuppliesCurrent		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q3	us-gaap	Other Assets OtherAssets		usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2024Q3	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
CY2023Q3	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2024Q3	FOXO	Stock Issued During Period Shares Shares Issuable For Myrtle Acquisition StockIssuedDuringPeriodSharesSharesIssuableForMyrtleAcquisition		usd
CY2024Q3	FOXO	Stock Issued During Period Shares Shares Issuable For Myrtle Acquisition StockIssuedDuringPeriodSharesSharesIssuableForMyrtleAcquisition		usd
CY2024Q3	FOXO	Stock Issued During Period Shares Shares Issuable To Institutional Investors Under Terms Of Senior Notes Payable StockIssuedDuringPeriodSharesSharesIssuableToInstitutionalInvestorsUnderTermsOfSeniorNotesPayable		usd
CY2024Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination		usd
	FOXO	Loss From Note Amendment And Debenture Release LossFromNoteAmendmentAndDebentureRelease		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments		usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Obligation Change In Rightofuse Lease Asset IncreaseDecreaseInChangeInRightofuseLeaseObligationChangeInRightofuseLeaseAsset		usd
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable		usd
	FOXO	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves		usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Liability IncreaseDecreaseInChangeInRightofuseLeaseLiability		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	FOXO	Payments Under Accounts Receivable Sales Agreements PaymentsUnderAccountsReceivableSalesAgreements		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent		usd
CY2023Q4	FOXO	Allowance For Discounts AllowanceForDiscounts		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q4	FOXO	Accounts Receivable Owed Under Sales AccountsReceivableOwedUnderSales		usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent		usd
CY2023Q4	FOXO	Accrued Interest Current AccruedInterestCurrent		usd
CY2023Q4	FOXO	Medicare Cost Report Settlement Reserves Current MedicareCostReportSettlementReservesCurrent		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease		usd
	FOXO	Debenture Release DebentureRelease		usd
	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment		usd
	FOXO	Deemed Dividends From Exchange Offer DeemedDividendsFromExchangeOffer		usd
	FOXO	Purchase Of Intangible Asset PurchaseOfIntangibleAsset		usd
	FOXO	Related Party Payable Tor Purchase Of Intangible Asset Under Kr8 Agreement RelatedPartyPayableTorPurchaseOfIntangibleAssetUnderKr8Agreement		usd
	FOXO	Stock Issued During Period Purchase Of Intangible Asset Under License Agreement StockIssuedDuringPeriodPurchaseOfIntangibleAssetUnderLicenseAgreement		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	FOXO	Warrants Issuable For Finders Fees WarrantsIssuableForFindersFees		usd
	FOXO	Stock Issued During Period Shares Issuable For Finders Warrants And Cash Fees StockIssuedDuringPeriodSharesIssuableForFindersWarrantsAndCashFees		usd
	FOXO	Stock Issued During Period Shares For Acquisition StockIssuedDuringPeriodSharesForAcquisition		usd
	FOXO	Promissory Note Issued For Acquisition PromissoryNoteIssuedForAcquisition		usd
	FOXO	Promissory Note Issued To Rhi For Rchi Acquisition PromissoryNoteIssuedToRhiForRchiAcquisition		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39783
	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N. Washington Ave.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
	dei	City Area Code CityAreaCode	(612)
	dei	Local Phone Number LocalPhoneNumber	562-9447
	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	FOXO
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17476574	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.0001
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2001000	usd
CY2024Q3	FOXO	Supplies Current SuppliesCurrent	210000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	502000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	86000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	162000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	109000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	2909000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	233000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4110000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2105000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	33160000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	100000	usd
CY2024Q3	us-gaap	Assets Assets	42671000	usd
CY2023Q4	us-gaap	Assets Assets	725000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8204000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4556000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12557000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3986000	usd
CY2024Q3	FOXO	Related Parties Payables And Accruals RelatedPartiesPayablesAndAccruals	3682000	usd
CY2023Q4	FOXO	Related Parties Payables And Accruals RelatedPartiesPayablesAndAccruals	801000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14336000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3771000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	481000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14825000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162959000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-177060000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-14100000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-46000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14100000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	725000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35000	usd
CY2024Q3	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues	541000	usd
	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues	572000	usd
	FOXO	Direct Costs Of Revenues DirectCostsOfRevenues	70000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	925000	usd
	FOXO	Management Contingent Share Plan Expense ManagementContingentSharePlanExpense	-141000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15052000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2201000	usd
	us-gaap	Operating Expenses OperatingExpenses	18469000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18504000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-244000	usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	957000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	148000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	865000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4088000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22592000	usd
	us-gaap	Profit Loss ProfitLoss	-22592000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
	FOXO	Deemed Dividend From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	3378000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25970000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6708000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7639000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	901000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-30000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13759000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	773000	usd
CY2023Q2	FOXO	Debenture Release DebentureRelease	2181000	usd
CY2023Q2	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment	1339000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2466000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-7030000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4572000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1447000	usd
CY2023Q3	FOXO	Stock Issued During Period Value Private Placements Net Of Issuance Costs StockIssuedDuringPeriodValuePrivatePlacementsNetOfIssuanceCosts	444000	usd
CY2023Q3	FOXO	Stock Issued During Period Value Issuance Of Common Stock To Joseph Gunner StockIssuedDuringPeriodValueIssuanceOfCommonStockToJosephGunner	221000	usd
CY2023Q3	FOXO	Issuance Of Common Stock To Msk IssuanceOfCommonStockToMsk	234000	usd
CY2023Q3	FOXO	Stock Granted During Period Value Deemed Dividend Related To Down Round Provison Of Assumed Warrants StockGrantedDuringPeriodValueDeemedDividendRelatedToDownRoundProvisonOfAssumedWarrants	912000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	135000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11103000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14100000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2160000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	103000	usd
CY2024Q1	FOXO	Shares Issued Under Kr Eight Agreement Value SharesIssuedUnderKREightAgreementValue	378000	usd
CY2024Q1	FOXO	Stock Issued During Period Value Share Issued Under Corporate Development And Advisory Agreement StockIssuedDuringPeriodValueShareIssuedUnderCorporateDevelopmentAndAdvisoryAgreement	153000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	16000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	17000	usd
CY2024Q1	FOXO	Deemed Dividends From Trigger Of Down Round Provisions DeemedDividendsFromTriggerOfDownRoundProvisions	656000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14937000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2473000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issuable Under Terms Of Note Payable StockIssuedDuringPeriodValueSharesIssuableUnderTermsOfNotePayable	28000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issued To Lgh Under Terms Of Note Payable StockIssuedDuringPeriodValueSharesIssuedToLghUnderTermsOfNotePayable	57000	usd
CY2024Q2	FOXO	Stock Issued During Period Value Shares Issued For Legal Settlement StockIssuedDuringPeriodValueSharesIssuedForLegalSettlement	286000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	43000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Shares Issuable For Myrtle Acquisition StockIssuedDuringPeriodSharesSharesIssuableForMyrtleAcquisition	235000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Shares Issuable To Institutional Investors Under Terms Of Senior Notes Payable StockIssuedDuringPeriodSharesSharesIssuableToInstitutionalInvestorsUnderTermsOfSeniorNotesPayable	255000	usd
CY2024Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	38000	usd
CY2024Q2	FOXO	Stock Issued During Period Shares Deemed Dividends From Trigger Of Down Round Provisions Of Assumed Warrant StockIssuedDuringPeriodSharesDeemedDividendsFromTriggerOfDownRoundProvisionsOfAssumedWarrant	310000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2034000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-93000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	24000	usd
CY2024Q3	FOXO	Stock Issued During Period Valueshares Issuable For Corporate Development And Advisory Services StockIssuedDuringPeriodValuesharesIssuableForCorporateDevelopmentAndAdvisoryServices	393000	usd
CY2024Q3	FOXO	Stock Issued During Period Value Shares Issuable To Finder For Financial And Strategic Advisory Services StockIssuedDuringPeriodValueSharesIssuableToFinderForFinancialAndStrategicAdvisoryServices	165000	usd
CY2024Q3	FOXO	Stock Issued During Period Value Shares Issued For Legal Settlement StockIssuedDuringPeriodValueSharesIssuedForLegalSettlement	29000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2000	usd
CY2024Q3	FOXO	Stock Issued During Period Value Shares Issuable To Finder In Lieu Of Finders Warrants And Fees StockIssuedDuringPeriodValueSharesIssuableToFinderInLieuOfFindersWarrantsAndFees	47000	usd
CY2024Q3	FOXO	Stock Issued During Period Shares Deemed Dividends From Trigger Of Down Round Provisions Of Assumed Warrant StockIssuedDuringPeriodSharesDeemedDividendsFromTriggerOfDownRoundProvisionsOfAssumedWarrant	88000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17554000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17554000	usd
	us-gaap	Profit Loss ProfitLoss	-5621000	usd
	us-gaap	Profit Loss ProfitLoss	-22592000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	796000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1251000	usd
	FOXO	Loss From Note Amendment And Debenture Release LossFromNoteAmendmentAndDebentureRelease	-3521000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	94000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	361000	usd
	FOXO	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	502000	usd
	FOXO	Amortization Of Consulting Fees Paid In Common Stock AmortizationOfConsultingFeesPaidInCommonStock	2221000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	100000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-244000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	768000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	419000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	696000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	448000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	100000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-687000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	8000	usd
	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-182000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	87000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1835000	usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Obligation Change In Rightofuse Lease Asset IncreaseDecreaseInChangeInRightofuseLeaseObligationChangeInRightofuseLeaseAsset	1417000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3000	usd
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-18573000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1507000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1806000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-432000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1891000	usd
	FOXO	Increase Decrease In Policy Reserves IncreaseDecreaseInPolicyReserves	-18573000	usd
	FOXO	Increase Decrease In Change In Rightofuse Lease Liability IncreaseDecreaseInChangeInRightofuseLeaseLiability	1417000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-995000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6165000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-14000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	904000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	744000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1981000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	247000	usd
	FOXO	Payments Under Accounts Receivable Sales Agreements PaymentsUnderAccountsReceivableSalesAgreements	100000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	299000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	977000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	692000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5473000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_809_eus-gaap--NatureOfOperations_zSP4yk5tHiH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: -45.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Note 1 <span id="xdx_822_zYmkxmn9uthi">DESCRIPTION OF BUSINES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: -45.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOXO Technologies Inc. (“FOXO” or the “Company”), formerly known as Delwinds Insurance Acquisition Corp. (“Delwinds”), a Delaware corporation, was originally formed in April 2020 as a publicly traded special purpose company for the purpose of effecting a merger, capital stock exchange, asset acquisition, reorganization, or similar business combination involving one or more businesses. FOXO is commercializing epigenetic biomarker technology to support groundbreaking scientific research and disruptive next-generation business initiatives. The Company applies automated machine learning and artificial intelligence (“AI”) technologies to discover epigenetic biomarkers of human health, wellness and aging and, with the acquisitions of Myrtle Recovery Centers, Inc. (“Myrtle”), a Tennessee corporation, effective on June 14, 2024, and Rennova Community Health, Inc. (“RCHI”), a Florida corporation, and its wholly owned subsidiary, Scott County Community Hospital, Inc. (“SCCH”), a Tennessee corporation, on September 10, 2024, the Company offers behavioral health services, including substance abuse treatment and it operates a critical access designated hospital in Oneida, Tennessee. The acquisitions of Myrtle and RCHI are more fully discussed in Note 5.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages and classifies its business into two reportable business segments: (i) Healthcare; and (ii) Labs and Life. Previously, Labs and Life were treated as separate segments, however, with the acquisition of Myrtle in June 2024, the Company’s operational focus shifted such that it was appropriate to combine its Labs and Life segments during the second quarter of 2024 and to operate Myrtle, RCHI and SCCH under the Company’s recently formed Healthcare segment. SCCH is doing business as Big South Fork Medical Center (“BSF”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Business Combination</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 24, 2022, Delwinds entered into a definitive Agreement and Plan of Merger, dated as of February 24, 2022, as amended on April 26, 2022, July 6, 2022 and August 12, 2022 (the “Merger Agreement”), with FOXO Technologies Inc., now known as FOXO Technologies Operating Company (“FOXO Technologies Operating Company”), DWIN Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Delwinds (“Merger Sub”), and DIAC Sponsor LLC (the “Sponsor”), in its capacity as the representative of the stockholders of Delwinds from and after the closing (the “Closing”) of the transactions contemplated by the FOXO Transaction Agreement (collectively, the “Transaction” or the “Business Combination”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination was approved by Delwinds’ stockholders on September 14, 2022, and closed on September 15, 2022 (the “Closing Date”) whereby Merger Sub merged into FOXO Technologies Operating Company, with FOXO Technologies Operating Company surviving the merger as a wholly owned subsidiary of the Company (the “Combined Company”), and with FOXO Technologies Operating Company security holders becoming security holders of the Combined Company. Immediately upon the Closing, the name of Delwinds was changed to FOXO Technologies Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the Closing, FOXO became a holding company whose wholly-owned subsidiary, FOXO Technologies Operating Company, conducted all of the core business operations. FOXO Technologies Operating Company maintains its two wholly-owned subsidiaries, FOXO Labs Inc. and FOXO Life, LLC. FOXO Labs maintains a wholly-owned subsidiary, Scientific Testing Partners, LLC, while FOXO Life Insurance Company was a wholly-owned subsidiary of FOXO Life, LLC. On February 3, 2023, the Company sold FOXO Life Insurance Company as more fully discussed in Note 14. On June 14, 2024 and September 10, 2024, FOXO acquired Myrtle and RCHI, respectively, as more fully discussed in Note 5.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25970000	usd
CY2024Q3	FOXO	Working Capital Deficit WorkingCapitalDeficit	31439000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-17554000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-995000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6165000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-16167000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z9B690OoaPN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECLASSIFICATIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase of the intangible asset under the KR8 Agreement, which is defined and discussed in Note 11, was previously reflected as a use of cash in the investing activities of the cash flow statement with the corresponding accrued liability reflected in the operating activity section of the cash flow statement. These amounts have been reclassified to the supplemental cash flow information presented in Note 17. </span>The following table presents the effects of the reclassifications for the periods presented:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_89D_ecustom--ScheduleOfReclassificationOfCashFlowStatementTableTextBlock_z7Ckbhmh62f8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B9_zjJ22nOx03Qk" style="display: none">SCHEDULE OF RECLASSIFICATIONS</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20240101__20240630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1vV4btL9wz4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Presented</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" id="xdx_495_20240101__20240630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zt8U3Ee6VrTh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" id="xdx_498_20240101__20240630_z1AFCZt6xUri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Revised</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Presented</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Revised</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_z6Qdr74MlnA9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Net cash provided by (used in) operating activities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">551</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(2,122</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(1,571</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInInvestingActivities_pn3n3_zvkwqHHcxiOh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,381</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,122</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(259</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_pn3n3_zUitTRpuakq9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net change in cash</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,830</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,830</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--NoncashRelatedPartyPayableForPurchaseOfIntangibleAsset_pn3n3_zXWe2exoUC41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-cash related party payable for purchase of intangible asset</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1027">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,122</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,122</td><td style="text-align: left"> </td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20240101__20240331__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5dlqqkRgC9c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Presented</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20240101__20240331__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zglXclKONx0j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_494_20240101__20240331_zyYjrEno53p2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Revised</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Marh 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: right"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: center"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Presented</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Revised</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_zSPEZ64b17Pb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Net cash provided by (used in) operating activities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,716</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(2,122</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(406</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_pn3n3_zslYAmB7v8r8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,122</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,122</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1037">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_pn3n3_zFE6OrDuL02b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net change in cash</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(406</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1040">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(406</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--NoncashRelatedPartyPayableForPurchaseOfIntangibleAsset_pn3n3_zMtbEUE9iLGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-cash related party payable for purchase of intangible asset</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1043">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,122</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,122</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_zH7Yeqci3E3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In addition, certain items in the 2023 financial statements have been reclassified for comparison purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1571000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1830000	usd
	FOXO	Noncash Related Party Payable For Purchase Of Intangible Asset NoncashRelatedPartyPayableForPurchaseOfIntangibleAsset	2122000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-406000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-406000	usd
CY2024Q1	FOXO	Noncash Related Party Payable For Purchase Of Intangible Asset NoncashRelatedPartyPayableForPurchaseOfIntangibleAsset	2122000	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
CY2024Q3	FOXO	Contractual Allowances ContractualAllowances	4047000	usd
	FOXO	Contractual Allowances ContractualAllowances	4137000	usd
CY2024Q3	FOXO	Contractual Allowance Related Adjustments ContractualAllowanceRelatedAdjustments	1188000	usd
	FOXO	Contractual Allowance Related Adjustments ContractualAllowanceRelatedAdjustments	1208000	usd
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	3334	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	69668	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1946000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5613000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	88000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	912000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1054000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3378000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2034000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4572000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6667000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25970000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5872797000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3260815000	shares
	FOXO	Legal Costs LegalCosts	5000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	22000000	usd
CY2024Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3041000	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3510000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	9706000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	14735000	usd
CY2024Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-2785000	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-3401000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-7483000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-17767000	usd
CY2024Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	88000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	912000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1054000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	3378000	usd
CY2024Q3	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-2873000	usd
CY2023Q3	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-4313000	usd
	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-8537000	usd
	FOXO	Business Acquisition Pro Forma Net Income Loss Available To Common Stockholders Basic BusinessAcquisitionProFormaNetIncomeLossAvailableToCommonStockholdersBasic	-21145000	usd
CY2024Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.22
CY2024Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.22
CY2023Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.73
CY2023Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.73
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.74
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.74
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-4.83
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-4.83
CY2024Q3	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	13334	shares
CY2024Q3	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	13334	shares
CY2023Q3	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	5902	shares
CY2023Q3	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	5902	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	11553	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	11553	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageNumberOfSharesOutstandingBasic	4374	shares
	FOXO	Business Acquisition Pro Forma Weighted Average Number Of Diluted Shares Outstanding BusinessAcquisitionProFormaWeightedAverageNumberOfDilutedSharesOutstanding	4374	shares
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	12900000	usd
CY2024Q3	FOXO	Allowance For Discounts AllowanceForDiscounts	9354000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1119000	usd
CY2024Q3	FOXO	Accounts Receivable Owed Under Sales AccountsReceivableOwedUnderSales	426000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2001000	usd
CY2024Q3	FOXO	Accounts Receivable Owed Under Sales AccountsReceivableOwedUnderSales	426000	usd
	FOXO	Defaulted Accounts Receivable Sale DefaultedAccountsReceivableSale	91000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	434000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	387000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	17000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	5000	usd
	us-gaap	Depreciation Depreciation	24000	usd
	us-gaap	Depreciation Depreciation	23000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	214000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2105000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	257000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	773000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1228000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	2633000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	33160000	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4598000	usd
CY2024Q3	FOXO	Accrued Severance Current AccruedSeveranceCurrent	2072000	usd
CY2023Q4	FOXO	Accrued Severance Current AccruedSeveranceCurrent	1696000	usd
CY2024Q3	FOXO	Accrued Interest Current AccruedInterestCurrent	621000	usd
CY2024Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1945000	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	2260000	usd
CY2024Q3	FOXO	Medicare Cost Report Settlement Reserves Current MedicareCostReportSettlementReservesCurrent	2097000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1224000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12557000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3986000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4065000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	31565000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	4993000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9565000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4993000	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	22000000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4110000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3771000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4110000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y6M
CY2024Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.220	pure
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	41000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	46000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	113000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	128000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	1212000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	1248000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	1285000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	1324000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	1363000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	945000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7377000	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	3267000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4110000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3771000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	FOXO	Shares Authorized SharesAuthorized	510000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	FOXO	Percentage Of Exercise Price PercentageOfExercisePrice	1.10	pure
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	25672	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	598877	shares
CY2024Q1	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2024-02-24
	FOXO	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exerciable ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExerciable	4726514	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.216
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	25868	shares
CY2023Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	5002000	usd
CY2023Q1	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	200000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	251000	usd
CY2023Q3	FOXO	Merger Consideration And Buyers Third Party Expenses Transaction Gain MergerConsiderationAndBuyersThirdPartyExpensesTransactionGain	4751000	usd
CY2024Q3	us-gaap	Assets Assets	42671000	usd
CY2023Q4	us-gaap	Assets Assets	725000	usd
CY2024Q3	us-gaap	Revenues Revenues	1196000	usd
CY2023Q3	us-gaap	Revenues Revenues	10000	usd
CY2024Q3	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-429000	usd
CY2023Q3	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-408000	usd
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	957000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	148000	usd
CY2024Q3	us-gaap	Revenues Revenues	1196000	usd
CY2023Q3	us-gaap	Revenues Revenues	10000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1946000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3660000	usd
CY2024Q3	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	308000	usd
CY2023Q3	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	1312000	usd
	us-gaap	Revenues Revenues	1231000	usd
	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-1366000	usd
	FOXO	Net Income Loss From Segments NetIncomeLossFromSegments	-1494000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2633000	usd
	FOXO	Loss From Pik Note Amendment And Debenture Release LossFromPikNoteAmendmentAndDebentureRelease	-3521000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1800000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	865000	usd
	us-gaap	Revenues Revenues	1231000	usd
	us-gaap	Revenues Revenues	35000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5613000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22592000	usd
	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	397000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15000	usd
	FOXO	Amortization Of Consulting Fees AmortizationOfConsultingFees	2582000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-244000	usd
CY2024Q3	FOXO	Accrued Settlement AccruedSettlement	1974000	usd
CY2023Q4	FOXO	Accrued Settlement AccruedSettlement	2260000	usd
CY2022Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	6207000	usd
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	300000	usd
CY2024Q3	us-gaap	Accelerated Share Repurchases Settlement Payment Or Receipt AcceleratedShareRepurchasesSettlementPaymentOrReceipt	50000	usd
	FOXO	Revenues Received Percentage RevenuesReceivedPercentage	0.15	pure
	us-gaap	Severance Costs1 SeveranceCosts1	1575000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	1575000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	462000	usd
CY2024Q3	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	822000	usd
CY2024Q4	us-gaap	Notes Payable NotesPayable	650000	usd
CY2024Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.5001	pure
	FOXO	Debenture Release DebentureRelease	2181000	usd
	FOXO	Payment In Kind Note Amendment PaymentInKindNoteAmendment	1339000	usd
	FOXO	Deemed Dividends From Exchange Offer DeemedDividendsFromExchangeOffer	2466000	usd
	FOXO	Purchase Of Intangible Asset PurchaseOfIntangibleAsset	2122000	usd
	FOXO	Related Party Payable Tor Purchase Of Intangible Asset Under Kr8 Agreement RelatedPartyPayableTorPurchaseOfIntangibleAssetUnderKr8Agreement	2122000	usd
	FOXO	Stock Issued During Period Purchase Of Intangible Asset Under License Agreement StockIssuedDuringPeriodPurchaseOfIntangibleAssetUnderLicenseAgreement	378000	usd
	FOXO	Deemed Dividends From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendsFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	1054000	usd
	FOXO	Deemed Dividends From Trigger Of Down Round Provisions And Extension Of Assumed Warrants DeemedDividendsFromTriggerOfDownRoundProvisionsAndExtensionOfAssumedWarrants	912000	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	364000	usd
	FOXO	Warrants Issuable For Finders Fees WarrantsIssuableForFindersFees	62000	usd
	FOXO	Stock Issued During Period Shares Issuable For Finders Warrants And Cash Fees StockIssuedDuringPeriodSharesIssuableForFindersWarrantsAndCashFees	47000	usd
	FOXO	Stock Issued During Period Shares For Acquisition StockIssuedDuringPeriodSharesForAcquisition	235000	usd
	FOXO	Promissory Note Issued For Acquisition PromissoryNoteIssuedForAcquisition	265000	usd
	FOXO	Promissory Note Issued To Rhi For Rchi Acquisition PromissoryNoteIssuedToRhiForRchiAcquisition	22000000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-046738-index-headers.html	Edgar Link	pending
0001493152-24-046738-index.html	Edgar Link	pending
0001493152-24-046738.txt	Edgar Link	pending
0001493152-24-046738-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-2_004.jpg	Edgar Link	pending
ex10-2_005.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-3_001.jpg	Edgar Link	pending
ex10-3_002.jpg	Edgar Link	pending
ex10-3_003.jpg	Edgar Link	pending
ex10-3_004.jpg	Edgar Link	pending
ex10-3_005.jpg	Edgar Link	pending
ex10-3_006.jpg	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-4_002.jpg	Edgar Link	pending
ex10-4_003.jpg	Edgar Link	pending
ex10-4_004.jpg	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex10-4_006.jpg	Edgar Link	pending
ex10-4_007.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-5_003.jpg	Edgar Link	pending
ex10-5_004.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
foxo-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
foxo-20240930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
foxo-20240930_pre.xml	Edgar Link	unprocessable
foxo-20240930_def.xml	Edgar Link	unprocessable
foxo-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q4 Form 10-Q Financial Statement

#000149315224046738 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2024 Q4 Form 10-Q Financial Statement

#000149315224046738 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo